Compare Stocks

Chilean Metals Inc., a mining exploration company, engages in the acquisition and exploration of mineral properties in Chile and Canada. The company explores for gold, silver, copper, lithium, nickel, cobalt, and iron deposits. It owns 100% interest in Zulema property covering an area of approximately 4,300 hectares situated in the Atacama mineral belt in Chile's 3rd region; Palo Negro and Hornitos properties that covers an area of approximately 9,000 hectares located in the Atacama Province of Chile's 3rd region; and Tierra de Oro property covering an area of approximately 5,667 hectares located in the Chile's prolific iron oxide-copper-gold belt. In addition, the company has interests in Parrsboro and Lynn properties, Canada; and owns additional mining concessions in Hornitos, Palo Negro, and Tabaco properties located in Chile. Further, it has an option to acquire a 50% interest in the Nisk property; and 100% interest in Golden Ivan property consisting of 13 mineral claims covering an area of approximately 797 hectares located in British Columbia. The company was formerly known as International PBX Ventures Ltd. and changed its name to Chilean Metals Inc. in February 2014. Chilean Metals Inc. was incorporated in 1987 and is headquartered in Toronto, Canada.

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Miami, Florida.

Silicon Graphics International Corp. (SGI) is engaged in providing solutions for compute, data analytics and data management. The Company develops, markets and sells a line of mid-range and high-end scale-out and scale-up servers, enterprise-class storage, differentiating software and designed-to-order solutions for data center deployments. The Company operates through the segments, including Product and Service. The Company's Product segment consists of compute and storage solutions, which include products from both HPC and HPDA segments. The Company's Product segment includes scale-out computing, scale-up computing, software and cloud/Web solutions. Its storage solutions include both hardware and software offerings for data storage and management. The Service segment consists of customer service support and professional services. SGI systems enable customers to access, analyze, transform, manage and visualize information in real and near real-time.